Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-10 Sale | 2026-03-12 3:58 pm | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 13,720 | $0.8 | $10,976 | 215,200 (Direct) | View |
| 2026-03-01 Purchase | 2026-03-03 08:49 am | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Wambeke David J. Chief Business Officer | 1,000,000 | $0.6704 | $670,400 | 1,500,000 (Direct) | View |
| 2025-09-05 Sale | 2025-09-09 4:15 pm | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 30,000 | $0.7401 | $22,203 | 231,238 (Direct) | View |
| 2025-06-04 Sale | 2025-06-05 4:08 pm | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 10,000 | $0.5804 | $5,804 | 261,491 (Direct) | View |
| 2025-05-21 Sale | 2025-05-23 4:03 pm | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 8,981 | $0.62304 | $5,596 | 271,491 (Direct) | View |
| 2025-05-19 Sale | 2025-05-21 4:14 pm | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 11,019 | $0.66299 | $7,306 | 280,472 (Direct) | View |
| 2025-04-04 Purchase | 2025-04-07 4:47 pm | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | McClurg Ronald W. Chief Financial Officer | 200,000 | $0.5 | $100,000 | 444,117 (Direct) | View |
| 2025-04-04 Purchase | 2025-04-07 4:38 pm | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President | 100,000 | $0.5 | $50,000 | 1,161,289 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-01 Option Award | 2026-03-03 08:49 am | N/A 2036-02-29 | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Wambeke David J. Chief Business Officer | 500,000 | $0 | 1,500,000 (Direct) | View |
| 2026-02-18 Tax Withholding | 2026-02-20 2:27 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer | 7,376 | $0.68 | 153,047 (Direct) | View |
| 2026-02-18 Tax Withholding | 2026-02-20 2:20 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 1,812 | $0.68 | 228,920 (Direct) | View |
| 2026-02-18 Tax Withholding | 2026-02-20 2:15 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President | 71,325 | $0.68 | 1,082,590 (Direct) | View |
| 2025-12-31 Tax Withholding | 2026-01-05 4:46 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer | 906 | $0.758 | 160,423 (Direct) | View |
| 2025-12-31 Tax Withholding | 2026-01-05 4:38 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President | 2,458 | $0.758 | 1,153,915 (Direct) | View |
| 2025-12-31 Tax Withholding | 2026-01-05 4:11 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 253 | $0.758 | 230,732 (Direct) | View |
| 2025-12-18 Option Award | 2026-01-02 12:03 pm | N/A 2035-12-18 | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mills Jason Richard Director | 12,564 | $0 | 12,564 (Direct) | View |
| 2025-09-30 Tax Withholding | 2025-10-01 2:20 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer | 906 | $0.8886 | 161,329 (Direct) | View |
| 2025-09-30 Tax Withholding | 2025-10-01 2:15 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 253 | $0.8886 | 230,985 (Direct) | View |
| 2025-09-30 Tax Withholding | 2025-10-01 2:05 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President | 2,458 | $0.8886 | 1,156,373 (Direct) | View |
| 2025-06-30 Tax Withholding | 2025-07-02 12:22 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 253 | $0.678 | 261,238 (Direct) | View |
| 2025-06-30 Tax Withholding | 2025-07-02 10:58 am | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer | 906 | $0.678 | 162,235 (Direct) | View |
| 2025-06-30 Tax Withholding | 2025-07-02 10:42 am | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President | 2,458 | $0.678 | 1,158,831 (Direct) | View |
| 2025-06-23 Option Award | 2025-06-25 3:47 pm | N/A 2035-06-23 | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | MATHIESEN JEFFREY S Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2025-06-23 Option Award | 2025-06-25 3:42 pm | N/A 2035-06-23 | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | BUCKMAN PAUL Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2025-06-23 Option Award | 2025-06-25 3:34 pm | N/A 2035-06-23 | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Andrle Edward Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2025-06-01 Option Award | 2025-06-03 3:45 pm | N/A 2035-05-31 | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Johns Emily J. General Counsel | 500,000 | $0 | 500,000 (Direct) | View |
| 2025-04-17 Option Award | 2025-04-21 5:11 pm | N/A 2035-04-16 | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 200,000 | $0 | 200,000 (Direct) | View |
| 2025-04-17 Option Award | 2025-04-21 5:02 pm | N/A 2035-04-16 | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2025-04-17 Option Award | 2025-04-21 4:54 pm | N/A 2035-04-16 | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Volker Christopher Chief Operating Officer | 575,000 | $0 | 575,000 (Direct) | View |
| 2025-04-17 Option Award | 2025-04-21 4:44 pm | N/A 2035-04-16 | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | McClurg Ronald W. Chief Financial Officer | 250,000 | $0 | 250,000 (Direct) | View |
| 2025-04-17 Option Award | 2025-04-21 4:34 pm | N/A 2035-04-16 | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President | 750,000 | $0 | 750,000 (Direct) | View |
| 2025-03-31 Tax Withholding | 2025-04-02 4:11 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer | 906 | $0.8502 | 163,141 (Direct) | View |
| 2025-03-31 Tax Withholding | 2025-04-02 4:04 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 253 | $0.8502 | 291,491 (Direct) | View |
| 2025-03-31 Tax Withholding | 2025-04-02 3:56 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President | 2,458 | $0.8502 | 1,061,289 (Direct) | View |
| 2025-02-18 Tax Withholding | 2025-02-20 4:47 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer | 7,376 | $1.16 | 164,047 (Direct) | View |
| 2025-02-18 Tax Withholding | 2025-02-20 4:13 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 1,812 | $1.16 | 291,744 (Direct) | View |
| 2025-02-18 Tax Withholding | 2025-02-20 4:05 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President | 71,325 | $1.16 | 1,063,747 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-19 12:18 pm | N/A 2035-02-14 | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | BUCKMAN PAUL Director | 44,803 | $0 | 153,829 (Direct) | View |